Previous Article | Next Article 
Journal of Virology, January 1999, p. 760-766, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Fine Structure and Morphogenesis of Borna
Disease Virus
Takehiro
Kohno,1
Toshiyuki
Goto,1,*
Tomohiko
Takasaki,2,
Chizuko
Morita,1
Takaaki
Nakaya,3
Kazuyoshi
Ikuta,3
Ichiro
Kurane,4
Kouichi
Sano,1 and
Masuyo
Nakai5
Department of
Microbiology,1
Osaka Medical
College,5 Takatsuki, Osaka 569-8686, Department of Microbiology, Kinki University School of
Medicine, Osaka-sayama, Osaka 589-8511,2
Institute of Immunological Science, Hokkaido University,
Kita-ku, Sapporo, Hokkaido 060-0815,3 and
Department of Virology I, National Institute of Infectious
Disease, Toyama, Shinjuku-ku, Tokyo 162-8640,4
Japan
Received 11 May 1998/Accepted 16 September 1998
 |
ABSTRACT |
Borna disease virus (BDV), a negative nonsegmented single-stranded
RNA virus, has not been fully characterized morphologically. Here
we present what is to our knowledge the first data on the fine
ultrastructure and morphogenesis of BDV. The supernatant of MDCK cells
persistently infected with BDV treated with n-butyrate contained many virus-like particles and more BDV-specific RNA than that
of untreated samples. The particles were spherical, enveloped, and
approximately 130 nm in diameter; had spikes 7 nm in length; and
reacted with BDV p40 antibody. A thin nucleocapsid, 4 nm in width, was
present peripherally in contrast to the thick nucleocapsid
of hemagglutinating virus of Japan. The BDV particles reproduced by
budding on the cell surface.
 |
TEXT |
Borna disease virus (BDV) is the
etiological agent for Borna disease, which is a central nervous system
disease characterized by profound behavioral abnormalities,
inflammatory cell infiltrates in the central nervous system, and
accumulation of BDV-specific proteins in the limbic system neurons (for
reviews, see references 21, 23 and
28). Though natural infection has only been
confirmed to occur in horses and sheep, the potential host range of BDV includes other mammals and birds (4, 24, 25). Demonstration of specific viral antigens in patients with affective disorders suggests that BDV or a related virus may be pathogenic to humans as
well (1-3, 5, 30, 31). More recently, BDV RNA has been frequently detected in peripheral blood mononuclear cells from patients
with neuropsychiatric disorders (6, 18, 19, 33) and in the
brain tissue of schizophrenics and depressives (32). The
broad spectrum of animal hosts for BDV indicates that transmission of
the virus most likely occurs via extracellular virus particles.
BDV is a negative nonsegmented single-stranded (NNS) RNA virus with a
genomic organization similar to that of other members of the order
Mononegavirales (8, 11), including the families Paramyxoviridae, Rhabdoviridae, and
Filoviridae. However, in contrast to those of other animal
NNS RNA viruses, BDV replication and transcription occur in the nucleus
(7, 8, 10, 37), and BDV uses RNA splicing for the regulation
of its gene expression (12, 34, 35). These findings have led
to the classification of a new family of animal NNS RNA viruses, the
Bornaviridae (27).
Many attempts to identify BDV particles by electron microscopy have
been made. To identify the rare virus particles in vitro as well as in
vivo, several investigators have used techniques for high virus yields
(15, 22, 29, 37) and purification. In the purification
techniques (22, 29), BDV particles were obtained by affinity
chromatography purification or lipid extraction with Freon. Therefore,
these particles were condensed to 50 to 60 nm in diameter during
extraction with high salt concentrations or were reduced in diameter
due to removal of the envelope. Pauli and Ludwig (26)
developed high-yield virus infectivity systems by the addition of salts
or n-butyrate. Zimmermann et al. (37) used a
system with a higher concentration of salts to identify the virion of
BDV as an enveloped particle ranging from 50 to 100 nm in diameter, by
electron microscopic negative staining. The trials were also extended
to hypertonic treatment to promote the release of cell-bound
viruses (7, 15). They confirmed the presence of particles
ranging from 80 to 130 nm in diameter by negative staining. However,
they did not determine the morphology, especially the inner
structure, in detail. Compans et al. (9) observed
intracytoplasmic virus particles in ultrathin sections, but the
fine structure and morphogenesis of the extracellular virus have not
been well characterized.
The development of a method for higher BDV yields by treatment
with n-butyrate in Madin-Darby canine kidney (MDCK)
cells persistently infected with BDV (MDCK/BDV cells)
(26) prompted us to attempt visualization of the virus
particles by electron microscopy. Here we present the first data, to
our knowledge, on the fine ultrastructure and morphogenesis of BDV
cultured in cells persistently infected with BDV.
The MDCK/BDV cell line (16) was kindly provided by
R. Rott, Justus-Liebig-Universität Giessen, Giessen,
Germany. The cells were cultured in Dulbecco's minimum essential
medium (Dainippon Pharmaceutical Co. Ltd., Osaka, Japan) at 37°C for
24 h in a plastic culture flask. In order to induce the production
of BDV particles with n-butyrate, the cells were further
incubated in the same medium containing 8 mM n-butyric acid
sodium salt (Sigma, St. Louis, Mo.) at 37°C for 48 h as
previously described (26). The n-butyrate-induced
MDCK/BDV (referred to as induced MDCK/BDV) cell culture and its
supernatant were compared with those of uninduced MDCK/BDV cells and
non-BDV-infected MDCK cells cultured under the same conditions. For
comparison, Molt-4 or MDCK cells were inoculated with human
immunodeficiency virus type 1 (HIV-1, strain BRU) and a paramyxovirus,
hemagglutinating virus of Japan (HVJ) (17), and cultured in
RPMI 1640 and Dulbecco's minimal essential medium, respectively. All
cell culture media were supplemented with 5% fetal bovine serum and
100 IU of penicillin and 100 µg of streptomycin per ml (GIBCO BRL,
Grand Island, N.Y.).
Detection of BDV-specific RNA in cultured supernatant.
Thirty-milliliter aliquots of the culture supernatants of induced
and uninduced MDCK/BDV cells were clarified by centrifugation at
2,200 × g for 5 min prior to filtration through a
0.45-µm-pore-size membrane (Millipore, Bedford, Mass.). The
filtrates were ultracentrifuged at 100,000 × g for 120 min, and the pellets were resuspended in 200 µl of 0.15 M
phosphate-buffered saline (pH 7.2) as a virus suspension for reverse
transcriptase PCR (RT-PCR) and negative staining. For RT-PCR assay,
RNAs were purified from the mixture of 100 µl of virus suspension and
5 µl of RNA suspension containing 105 copies of pAW109
RNA (Perkin-Elmer Corp., Branchburg, N.J.), using an RNA purification
kit (Invisorb RNA kit; ID Labs Biotechnology, London, Ontario,
Canada). The purified RNA was amplified by RT-PCR with the EZ rTth RNA
kit (Perkin-Elmer) and a primer pair for the BDV p40 gene. In
brief, the reverse transcription step was performed in a thermal cycler
(2400-k; Perkin-Elmer) at 60°C for 30 min, followed by 94°C for 2 min. The reverse transcripts were subsequently subjected to
amplification consisting of 35 cycles of denaturation at 94°C for 1 min and annealing and polymerization at 60°C for 1.5 min, followed by
a final polymerization step for 10 min at 60°C. The primers were
designed to detect PCR products of BDV p40 (36). The
sequences of the primers were as follows: 5'-GATGACGATCCTATCACAACC-3' (bp 339 to 359) and
5'-GTCACGGCGCGATATGTTTC-3' (bp 590 to 609).
The products of RT-PCR were analyzed by 10% polyacrylamide gel
electrophoresis with ethidium bromide staining. The intensity of each
band from induced and uninduced MDCK/BDV cell cultures and the standard
size marker of 300 bp were measured with the microcomputer imaging
device system of Imaging Research Inc. (St. Catharines, Ontario,
Canada). The quantities of BDV-specific RNA were expressed as relative
intensities on the basis of a standard size marker. The relative
intensities of the bands at 271 bp from induced and uninduced MDCK/BDV
cell cultures were semiquantitatively determined to be 180 and 26%,
respectively, by densitometric analysis in which a 300-bp marker band
was used as an intensity standard on the electrophoresis gel (data not
shown). The supernatant of the induced MDCK/BDV cell culture was shown
to contain more BDV-specific RNA than that of the uninduced MDCK/BDV
cell culture, though it remains to be clarified whether the
BDV-specific RNA is a part of viral RNA or mRNA which coded for BDV
p40, reported to be nucleoprotein (11). This increment of
BDV-specific RNA might indicate the induced production of the virus. We
speculated that there are more BDV particles in the supernatant
of induced MDCK/BDV cell cultures than in that of uninduced MDCK/BDV
cell cultures. Therefore, we subjected the
supernatants from induced MDCK/BDV cell cultures to negative staining.
Detection of virus-like particles in culture supernatant.
The
virus suspensions from induced MDCK/BDV cell cultures were mixed with
0.5% glutaraldehyde in 0.05 M cacodylate buffer (pH 7.2). The mixture
was poured on 300-mesh copper grids supported by hydrophilic
carbon-coated collodion films and left for 2 min at room temperature;
the excess suspension was removed by absorption with filter paper. The
grid was stained with 0.5% aqueous uranyl acetate solution for 1 min
and observed under an electron microscope (H-300; Hitachi, Tokyo,
Japan) at an accelerating voltage of 75 kV. In the suspension
from the induced MDCK/BDV cell culture, many spherical virus-like
particles were observed by negative staining (data not shown). Figure
1 shows the frequency distribution graph
for the diameters of the particles, indicating a bimodal distribution,
with two peaks in the ranges of 70 to 89 nm and 110 to 129 nm with wide
tails. The bimodal frequency distribution may suggest the existence of
two kinds of particles in the supernatant, which has also been reported
previously by Zimmermann et al. (37). To visualize the fine
structure and to confirm whether these particles were BDV, we examined
induced MDCK/BDV cells by ultrathin sectioning and immunoelectron
microscopy using anti-BDV p40 serum.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 1.
Distribution of the diameters of virus-like particles
observed by negative staining and ultrathin sectioning.
|
|
Visualization of the virus.
Cells were fixed with 0.2%
glutaraldehyde in 0.05 M cacodylate buffer (pH 7.2) for 3 min at room
temperature and collected with a plastic scraper. The cells were
suspended in 2% glutaraldehyde in the same buffer at 4°C for 60 min
and washed five times with the buffer. The fixed cells were further
fixed with 1% osmium tetroxide (OsO4) in the same buffer
at 4°C for 60 min, washed with the buffer, dehydrated in a graded
ethanol series, and embedded in epoxy resin. Ultrathin sections were
made with an ultramicrotome (Porter-Blum MT-5000; Sorvall, DuPont
Medical Products, Wilmington, Del.), stained doubly with uranyl acetate
and lead citrate, and observed under an electron microscope (H-7100;
Hitachi) at an accelerating voltage of 100 kV. For immunoelectron
microscopy, the collected cells were fixed in 1% glutaraldehyde in
0.05 M cacodylate buffer (pH 7.2) at 4°C for 60 min, dehydrated in a graded ethanol series, and embedded in Lowicryl K4M resin. Ultrathin sections were made in the same manner as that described above and
mounted on 300-mesh nickel grids supported by carbon-coated collodion
films. The ultrathin sections on the grids were treated with 5% normal
goat serum in phosphate-buffered saline to block nonspecific reactions.
The sections were reacted with a drop of rabbit antiserum against
recombinant BDV p40 (33) at room temperature for 60 min and
washed with 50 mM Tris-HCl buffer (pH 8.2). The sections were then
reacted again with anti-rabbit immunoglobulin G goat serum which had
been labeled with 10-nm-diameter colloidal gold (Amersham, Little
Chalfont, England) at room temperature for 60 min and were then
washed with the same buffer. The immunostained sections
were fixed with 1% glutaraldehyde in 0.05 M cacodylate buffer (pH 7.2)
at room temperature, washed with distilled water, immersed in a mixture
of 0.01% ruthenium red and 0.5% OsO4 in 0.05 M cacodylate
buffer (20), washed with distilled water, doubly stained
with uranyl acetate and lead citrate, and observed under an electron microscope.
Ultrathin sections of the induced MDCK/BDV cells embedded in epoxy
resin were examined to determine the fine structure and
morphogenesis
of the particles. The virus-like particles were
located in clusters in
the vicinity of the surfaces of the induced
MDCK/BDV cells (Fig.
2a). Particles were rarely observed in
cytoplasmic
vacuoles (Fig.
2b). The diameters of the particles,
including
those observed by negative staining, were distributed
bimodally
and ranged from 50 to 190 nm (Fig.
1). Each particle was
covered
by an envelope which possessed spikes approximately 7.0 ± 0.7
nm long (mean ± standard deviation) (Fig.
2a, inset). In the
particle,
we observed a crescent-shaped area which contained some
electron-dense
granules (Fig.
2a, inset).

View larger version (150K):
[in this window]
[in a new window]
|
FIG. 2.
Ultrathin section of induced MDCK/BDV cells embedded in
epoxy resin. (a) Extracellular virus-like particles. (Inset)
Extracellular virus-like particles at a high magnification. (b)
Virus-like particles in cytoplasmic vacuoles. Bars, 100 nm.
|
|
Virus-like particles embedded in Lowicryl K4M resin were also examined
by immunoelectron microscopy to determine whether they
contained BDV
antigens. The enveloped virus-like particles in
the vicinity of the
induced MDCK/BDV cells reacted with anti-BDV
p40 antibody (Fig.
3a); large particles ranging from 90 to
130
nm in diameter were labeled with anti-BDV p40 antibody, but small
particles, less than 90 nm in diameter, were not labeled (Fig.
3a).
Immunoelectron microscopic labeling of induced MDCK/BDV cells
with
normal rabbit serum (Fig.
3b) and MDCK/HVJ cells with anti-BDV
p40
antibody (Fig.
3c) did not reveal any positive results. The
labeling of
anti-BDV p40 antibody was mainly localized in electron-dense
areas in
the particles (Fig.
3a). These areas in some particles
were crescent
shaped or they lined the envelope, as observed in
the preparations
embedded in epoxy resin. This immunolabeling
procedure was also
confirmed for HIV-1-infected cells with a polyclonal
antibody for HIV-1
RT. HIV-1 particles reacted with anti-HIV-1
RT rabbit antibody when the
same procedure was used (Fig.
3d)
but did not react with normal rabbit
serum (Fig.
3e).

View larger version (172K):
[in this window]
[in a new window]
|
FIG. 3.
Antibody reactivity of BDV-, HVJ-, and HIV-infected
cells as detected by immunoelectron microscopy. (a) Induced MDCK/BDV
cells reacted with anti-BDV p40 antiserum. The arrow shows the budding
of BDV, and the arrowheads show particles that have reacted with the
antiserum. (b) Induced MDCK/BDV cells did not react with normal rabbit
serum. (c) MDCK/HVJ cells did not react with anti-BDV p40 antiserum.
(d) Molt-4/HIV-1 cells reacted with anti-HIV-1 RT rabbit serum. (e)
Molt-4/HIV-1 cells did not react with normal rabbit serum. Bars, 100 nm.
|
|
To confirm whether the granules existed inside the particles or in the
envelope spikes, sections were tilted and examined,
and stereoscopic
observation of electron micrographs (Fig.
4a
and b) revealed that most granules
were present inside the particles.
We compared the inner structures of
BDV and HVJ (Fig.
4c and d).
The nucleocapsids of HVJ were
approximately 20.8 ± 2.9 nm in width
(Fig.
4d and f), while those
of BDV were approximately 4.0 ± 1.0
nm (Fig.
4c and e). The total
lengths of the nucleocapsids could
not be determined in these sections.

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 4.
Inner structures of BDV and HVJ. Stereoscopic
observation of electron micrographs of virus-like particles observed in
ultrathin sections of induced MDCK/BDV cells embedded in epoxy resin.
The ultrathin sections were observed at tilts of +5° (a) and 5°
(b). (c) Ultrathin section of BDV particles, with an arrow showing the
thin nucleocapsid. (d) Ultrathin section of HVJ particles, with an
arrow showing the thick nucleocapsid. (e and f) Schematic diagrams of
BDV and HVJ, respectively.
|
|
The electron-dense granules in the BDV particle (Fig.
2a, inset) were
approximately 5.9 ± 2.8 nm in diameter, which was not
significantly different from the width of BDV nucleocapsids
(
P = 0.056). However, the electron-dense granules were
a little greater
in mean size than the nucleocapsid. This increment in
the granules
may depend on the attachments of some associated proteins,
such
as phosphoproteins or L proteins, which are suggested by the
nucleic
acid sequences (
8,
11). Thin nucleocapsids probably
tend
to gather in the peripheral region of the virion because the
nucleocapsid
did not fill the entire space of the virion, unlike that
of HVJ.
Therefore, the centers of most BDV particles appear to be less
electron dense. Elucidation of the detailed structure of the
nucleocapsid
of BDV must await the isolation of the nucleocapsids and
information
on the three-dimensional volume and shape of nucleoproteins
(p40
proteins).
Morphogenesis of BDV.
Spike-like structures were found on
parts of the surfaces of induced MDCK/BDV cells (Fig.
5a). The spiked membrane area was first
seen to be expanding, and the electron-dense fibrils were in line with
the area (Fig. 5b). The spiked membrane then grew into a hemisphere, at
which time the electron-dense granules were seen beneath the membrane
(Fig. 5c). Finally, the spiked membrane closed and became a separate
particle. The particle in Fig. 5d had probably just been released from
the cell surface. These findings suggest that the virus-like particles
reproduce by budding at the cell surface. It was confirmed by
immunoelectron microscopy that the buds react with the anti-BDV p40
antibody (Fig. 3a).

View larger version (166K):
[in this window]
[in a new window]
|
FIG. 5.
Sequential images of the budding process in induced
MDCK/BDV cells. The spiked membrane area (arrow in panel a) becomes an
extracellular particle (d). (b and c) Intermediate stages of the
budding. Bar, 100 nm.
|
|
Conclusions.
In the present study, we identified many
extracellular particles in the supernatants of induced MDCK/BDV cell
cultures according to the method of Pauli and Ludwig (26).
The particles were confirmed to be BDV by immunoelectron
microscopy. Zimmermann et al. (37) previously
identified BDV as enveloped particles in two sizes, 50 to 60 nm
and 90 nm in diameter, by negative staining after induction of a
BDV-infected human oligodendroglial cell line with high concentrations
of salt. They also demonstrated that both the large and small particles
carried BDV antigens, by immunoelectron microscopic negative staining
with antisera against BDV surface antigens. In this study, we used
antiserum against BDV inner antigens (p40) and found that the large
particles carried them but the small particles did not. Danner and Mayr
(13) reported that infectious BDV did not pass through a
membrane with a pore size of less than 80 nm, showing that the small
particles are probably a noninfectious incomplete form of BDV.
However, it remains to be clarified whether the small particles
are defective or immature, as described by Zimmermann et al.
(37). Compans et al. (9) found intracytoplasmic
virus-like particles in MDCK/BDV cells. We also identified such
particles in the cytoplasm (data not shown). However, we have not yet
observed any interactions, such as membrane fusion, between the
cytoplasmic particles and the cell membrane or any intracytoplasmic
particles attached to the cell surface. The pathway of the viral
constituents from the nucleus to the surface of the cell membrane could
not be determined in the present study.
The order
Mononegavirales, to which the family
Bornaviridae belongs, also includes
Rhabdoviridae,
Filoviridae, and
Paramyxoviridae.
Rhabdoviridae and
Filoviridae are filamentous and
Paramyxoviridae are spherical. Molecular
biological analyses suggest that BDV
resembles rhabdovirus (
11,
14). However, on the basis of particle
shape, BDV is
probably more similar to paramyxovirus than to rhabdovirus
or filovirus
because BDV is spherical. With regard to the inner
structure of the
virion of BDV, the nucleocapsids are observed
to be very thin
(approximately 4 nm) compared with those of HVJ
(approximately 21 nm).
The subunits of nucleocapsids in HVJ were
estimated to be 5 nm by
helical-pitch analysis (
17). Therefore,
we may only see the
nucleocapsid as a fibril of RNA, or probably
the p40 nucleoproteins do
not always cover the whole RNA genome.
Such features will be clarified
when we can directly observe BDV
nucleocapsids isolated from a large
number of extracellular
viruses.
Consequently, the characteristics of the particles that were observed
are as follows: (i) they are about 100 to 130 nm in
diameter, (ii) they
are covered by an envelope with approximately
7-nm-long spikes, (iii)
they have a crescent-like inner structure
with a nucleocapsid
approximately 4 nm in width, (iv) they reproduce
by budding at the cell
surface, and (v) they are associated with
incomplete small
particles.
 |
ACKNOWLEDGMENTS |
We thank R. Rott, Justus-Liebig-Universität Giessen, for
supplying the MDCK/BDV cell line; Juan Carlos de la Torre, The Scripps Research Institute, La Jolla, Calif., for supplying valuable antibody; and Luc Montagnier, Institut Pasteur, Paris, France, for supplying HIV
strain BRU. We also thank Yoshihiko Fujioka and Akie Hanada for expert
technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Osaka Medical College, 2-7 Daigaku-cho, Takatsuki, Osaka 569-8686, Japan. Phone: 81-726-83-1221, ext. 2647. Fax: 81-726-84-6517. E-mail: tgoto{at}art.osaka-med.ac.jp.
Present address: Department of Virology I, National Institute of
Infectious Disease, Tokyo, Japan.
 |
REFERENCES |
| 1.
|
Bode, L.,
S. Riegel,
H. Ludwig,
J. D. Amsterdam,
W. Lange, and H. Koprowski.
1988.
Borna disease virus-specific antibodies in patients with HIV infection and with mental disorders.
Lancet
ii:689.
|
| 2.
|
Bode, L.,
S. Riegel,
W. Lange, and H. Ludwig.
1992.
Human infections with Borna disease virus: seroprevalence in patients with chronic diseases and healthy individuals.
J. Med. Virol.
36:309-315[Medline].
|
| 3.
|
Bode, L.,
R. Ferszt, and G. Czech.
1993.
Borna disease virus infection and affective disorders in man.
Arch. Virol. Suppl.
7:159-167[Medline].
|
| 4.
|
Bode, L.,
R. Durrwald, and H. Ludwig.
1994.
Borna virus infections in cattle associated with fatal neurological disease.
Vet. Rec.
135:283-284[Medline].
|
| 5.
|
Bode, L.,
F. Steinbach, and H. Ludwig.
1994.
A novel marker for Borna disease virus infection.
Lancet
343:297-298.
|
| 6.
|
Bode, L.,
W. Zimmermann,
R. Ferszt,
F. Steinbach, and H. Ludwig.
1995.
Borna disease virus genome transcribed and expressed in psychiatric patients.
Nat. Med.
1:232-236[Medline].
|
| 7.
|
Briese, T.,
J. C. de la Torre,
A. Lewis,
H. Ludwig, and W. I. Lipkin.
1992.
Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of the infected cell.
Proc. Natl. Acad. Sci. USA
89:11486-11489[Abstract/Free Full Text].
|
| 8.
|
Briese, T.,
A. Schneemann,
A. Lewis,
Y.-S. Park,
S. Kim,
H. Ludwig, and W. I. Lipkin.
1994.
Genomic organization of Borna disease virus.
Proc. Natl. Acad. Sci. USA
91:4362-4366[Abstract/Free Full Text].
|
| 9.
|
Compans, R. W.,
L. R. Melsen, and J. C. de la Torre.
1994.
Virus-like particles in MDCK cells persistently infected with Borna disease virus.
Virus Res.
33:261-268[Medline].
|
| 10.
|
Cubitt, B., and J. C. de la Torre.
1994.
Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present.
J. Virol.
68:1371-1381[Abstract/Free Full Text].
|
| 11.
|
Cubitt, B.,
C. Oldstone, and J. C. de la Torre.
1994.
Sequence and genome organization of Borna disease virus.
J. Virol.
68:1382-1396[Abstract/Free Full Text].
|
| 12.
|
Cubitt, B.,
C. Oldstone,
J. Valcarcel, and J. C. de la Torre.
1994.
RNA splicing contributes to the generation of mature mRNAs of Borna disease virus, a non-segmented negative strand RNA virus.
Virus Res.
34:69-79[Medline].
|
| 13.
|
Danner, K., and A. Mayr.
1979.
In vitro studies on Borna virus. II. Properties of the virus.
Arch. Virol.
61:261-271[Medline].
|
| 14.
|
de la Torre, J. C.
1994.
Molecular biology of Borna disease virus: prototype of a new group of animal viruses.
J. Virol.
68:7669-7675[Free Full Text].
|
| 15.
|
Gonzalez-Dunia, D.,
B. Cubitt,
F. A. Grasser, and J. C. de la Torre.
1997.
Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry.
J. Virol.
71:3208-3218[Abstract].
|
| 16.
|
Herzog, S., and R. Rott.
1980.
Replication of Borna disease virus in cell cultures.
Med. Microbiol. Immunol.
168:153-158[Medline].
|
| 17.
|
Hosaka, Y., and J. Hosoi.
1983.
Study of negatively stained images of Sendai virus nucleocapsids using minimum-dose system.
J. Ultrastruct. Res.
84:140-150[Medline].
|
| 18.
|
Kishi, M.,
T. Nakaya,
Y. Nakamura,
Q. Zhong,
K. Ikeda,
M. Senjo,
M. Kakinuma,
S. Kato, and K. Ikuta.
1995.
Demonstration of human Borna disease virus RNA in human peripheral blood mononuclear cells.
FEBS Lett.
364:293-297[Medline].
|
| 19.
|
Kishi, M.,
Y. Arimura,
K. Ikuta,
Y. Shoya,
P. K. Lai, and M. Kakinuma.
1996.
Sequence variability of Borna disease virus open reading frame II found in human peripheral blood mononuclear cells.
J. Virol.
70:635-640[Abstract].
|
| 20.
|
Kohno, T.,
Y. Fujioka,
T. Goto,
S. Morimatsu,
C. Morita,
T. Nakano, and K. Sano.
1998.
Contrast-enhancement for the image of human immunodeficiency virus from ultrathin section by immunoelectron microscopy.
J. Virol. Methods
72:137-143[Medline].
|
| 21.
|
Lipkin, W. I.,
T. Briese, and J. C. de la Torre.
1992.
Borna disease virus: molecular analysis of a neurotropic infectious agent.
Microb. Pathog.
13:167-170[Medline].
|
| 22.
|
Ludwig, H., and H. Becht.
1977.
Borna disease a summary of our present knowledge, p. 75-83.
In
V. ter Meulen, and M. Katz (ed.), Slow virus infections of the central nervous system. Investigational approaches to etiology and pathogenesis of these diseases. Springer-Verlag, New York, N.Y.
|
| 23.
|
Ludwig, H.,
L. Bode, and G. Gosztonyi.
1988.
Borna disease: a persistent virus infection of the central nervous system.
Prog. Med. Virol.
35:107-151[Medline].
|
| 24.
|
Lundgren, A. L.,
G. Czech,
L. Bode, and H. Ludwig.
1993.
Natural Borna disease in domestic animals other than horses and sheep.
J. Vet. Med.
40:298-303.
|
| 25.
|
Malkinson, M.,
Y. Weisman,
E. Ashash,
L. Bode, and H. Ludwig.
1993.
Borna disease in ostriches.
Vet. Rec.
133:304[Medline].
|
| 26.
|
Pauli, G., and H. Ludwig.
1985.
Increase of virus yields and releases of Borna disease virus from persistently infected cells.
Virus Res.
2:29-33[Medline].
|
| 27.
|
Pringle, C. R.
1998.
The universal system of virus taxonomy of the International Committee on Virus Taxonomy (ICTV), including new proposals ratified since publication of the sixth ICTV report in 1995.
Arch. Virol.
143:203-209[Medline].
|
| 28.
|
Richt, J. A.,
S. Vande Woude,
M. C. Zink,
J. E. Clements,
S. Herzog,
L. Stitz,
R. Rott, and O. Narayan.
1992.
Infection with Borna disease virus: molecular and immunobiological characterization of the agent.
Clin. Infect. Dis.
14:1240-1250[Medline].
|
| 29.
|
Richt, J. A.,
J. E. Clements,
S. Herzog,
J. Pyper,
K. Wahn, and H. Becht.
1993.
Analysis of virus-specific RNA species and proteins in Freon-113 preparations of the Borna disease virus.
Med. Microbiol. Immunol.
182:271-280[Medline].
|
| 30.
|
Richt, J. A.,
S. Herzog,
J. Pyper,
J. E. Clements,
O. Narayan,
K. Bechter, and R. Rott.
1993.
Borna disease virus: nature of the etiologic agent and significance of infection in man.
Arch. Virol. Suppl.
7:101-109[Medline].
|
| 31.
|
Rott, R.,
S. Herzog,
B. Fleischer,
A. Winokur,
J. Amsterdam,
W. Dyson, and H. Koprowski.
1985.
Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders.
Science
228:755-756[Abstract/Free Full Text].
|
| 32.
|
Salvatore, M.,
S. Morzunov,
M. Schwemmle,
W. I. Lipkin, and the Bornavirus Study Group.
1997.
Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder.
Lancet
349:1813-1814[Medline].
|
| 33.
|
Sauder, C.,
A. Muller,
B. Cubitt,
J. Mayer,
J. Steinmetz,
W. Trabert,
B. Ziegler,
K. Wanke,
N. M. Lantzsch,
J. C. de la Torre, and F. A. Grasser.
1996.
Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA.
J. Virol.
70:7713-7724[Abstract].
|
| 34.
|
Schneemann, A.,
P. A. Schneider,
R. A. Lamb, and W. I. Lipkin.
1995.
The remarkable coding strategy of borna disease virus: a new member of the nonsegmented negative strand RNA viruses.
Virology
210:1-8[Medline].
|
| 35.
|
Schneider, P. A.,
A. Schneemann, and W. I. Lipkin.
1994.
RNA splicing in Borna disease virus, a nonsegmented, negative-strand RNA virus.
J. Virol.
68:5007-5012[Abstract/Free Full Text].
|
| 36.
|
Sierra-Honigmann, A. M.,
S. A. Rubin,
M. G. Estafanous,
R. H. Yolken, and K. M. Carbone.
1993.
Borna disease virus in peripheral blood mononuclear and bone marrow cells of neonatally and chronically infected rats.
J. Neuroimmunol.
45:31-36[Medline].
|
| 37.
|
Zimmermann, W.,
H. Breter,
M. Rudolph, and H. Ludwig.
1994.
Borna disease virus: immunoelectron microscopic characterization of cell-free virus and further information about the genome.
J. Virol.
68:6755-6758[Abstract/Free Full Text].
|
Journal of Virology, January 1999, p. 760-766, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bajramovic, J. J., Munter, S., Syan, S., Nehrbass, U., Brahic, M., Gonzalez-Dunia, D.
(2003). Borna Disease Virus Glycoprotein Is Required for Viral Dissemination in Neurons. J. Virol.
77: 12222-12231
[Abstract]
[Full Text]
-
Planz, O., Pleschka, S., Oesterle, K., Berberich-Siebelt, F., Ehrhardt, C., Stitz, L., Ludwig, S.
(2003). Borna Disease Virus Nucleoprotein Interacts with the Cdc2-Cyclin B1 Complex. J. Virol.
77: 11186-11192
[Abstract]
[Full Text]
-
Kraus, I., Eickmann, M., Kiermayer, S., Scheffczik, H., Fluess, M., Richt, J. A., Garten, W.
(2001). Open Reading Frame III of Borna Disease Virus Encodes a Nonglycosylated Matrix Protein. J. Virol.
75: 12098-12104
[Abstract]
[Full Text]